Daiichi In Massive $22bn Global Deal With Merck & Co For Three ADCs

New Validation Of DXd Platform

 
• By Lisa Takagi
  
Daiichi and MSD shook hands to co-develop and co-commercialize three ADCs outside Japan.
Daiichi and MSD agree to co-develop and co-commercialize three ADCs outside Japan • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business